Loading presentation...

Present Remotely

Send the link below via email or IM


Present to your audience

Start remote presentation

  • Invited audience members will follow you as you navigate and present
  • People invited to a presentation do not need a Prezi account
  • This link expires 10 minutes after you close the presentation
  • A maximum of 30 users can follow your presentation
  • Learn more about this feature in our knowledge base article

Do you really want to delete this prezi?

Neither you, nor the coeditors you shared it with will be able to recover it again.


Argus II

No description

Amber Erlenbeck

on 15 April 2013

Comments (0)

Please log in to add your comment.

Report abuse

Transcript of Argus II

Who invented it? The Argus II was invented by Second Sight Medical Products, a California based company. Founded in 1998 the company is designed to create, test and produce technology to help blind people regain their sight. The first clinical trial for Argus I began in 2002, the technology had been making progress ever since then. What is it? The Argus II is a bionic eye that gives blind people the ability to see. It has helped over 60 test subjects regain their vision. It consists of 60 electrodes implanted in the retina and glasses fitted with a special mini camera. The way the prosthesis works, is that it replaces the function of the photoreceptor. The photoreceptor is a cell that transmits light through the optic nerve, when the light gets to the brain it is decoded into images. Results vary throughout the patients, some only see in black and white, while others see in color. It is the first bionic eye to be put on the market in Europe and the U.S. It is already available in Europe for 73,000 Euros (99,120 U.S dollars), but the price is expected to be higher in the U.S. Argus II
Retinal Prosthesis System By: Amber Erlenbeck Who does it help? The Argus II was specially designed for people in the U.S suffering from retinitis pigmentosa, a rare genetic disease. This disease affects over 100,000 americans across the country, the disease results in degeneration of the photoreceptor, which turns into blindness. People from the ages of 28-77 took part in the clinical study, all of whom were completely blind. They are now up to 60 patients, with a lot of surgeries scheduled, and the number growing almost daily. Video! Bibliography www.youtube.com
Full transcript